These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30935967)

  • 1. Identification of two independent SUMO-interacting motifs in Fas-associated factor 1 (FAF1): Implications for mineralocorticoid receptor (MR)-mediated transcriptional regulation.
    Wang CH; Hung PW; Chiang CW; Lombès M; Chen CH; Lee KH; Lo YC; Wu MH; Chang WC; Lin DY
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1282-1297. PubMed ID: 30935967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation of SAP130 regulates its interaction with FAF1 as well as its protein stability and transcriptional repressor function.
    Chen CH; Lin HW; Huang MF; Chiang CW; Lee KH; Phuong NT; Cai ZY; Chang WC; Lin DY
    BMC Mol Cell Biol; 2024 Jan; 25(1):2. PubMed ID: 38172660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
    Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
    J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone.
    Yokota K; Shibata H; Kobayashi S; Suda N; Murai A; Kurihara I; Saito I; Saruta T
    Endocr Res; 2004 Nov; 30(4):611-6. PubMed ID: 15666800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation.
    Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D
    Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.
    Yokota K; Shibata H; Kurihara I; Kobayashi S; Suda N; Murai-Takeda A; Saito I; Kitagawa H; Kato S; Saruta T; Itoh H
    J Biol Chem; 2007 Jan; 282(3):1998-2010. PubMed ID: 17105732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-associated factor 1 is a scaffold protein that promotes β-transducin repeat-containing protein (β-TrCP)-mediated β-catenin ubiquitination and degradation.
    Zhang L; Zhou F; Li Y; Drabsch Y; Zhang J; van Dam H; ten Dijke P
    J Biol Chem; 2012 Aug; 287(36):30701-10. PubMed ID: 22730322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
    Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
    Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions.
    Santiago A; Godsey AC; Hossain J; Zhao LY; Liao D
    Cell Cycle; 2009 Jan; 8(1):76-87. PubMed ID: 19106612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.
    Holmstrom SR; Chupreta S; So AY; Iñiguez-Lluhí JA
    Mol Endocrinol; 2008 Sep; 22(9):2061-75. PubMed ID: 18562626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.
    Saether T; Pattabiraman DR; Alm-Kristiansen AH; Vogt-Kielland LT; Gonda TJ; Gabrielsen OS
    Oncogene; 2011 Jan; 30(2):212-22. PubMed ID: 20802522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XIAP Interacts with and Regulates the Activity of FAF1.
    Caballero-López MJ; Nieto-Díaz M; Yunta M; Reigada D; Muñoz-Galdeano T; Del Águila Á; Navarro-Ruíz R; Pita-Thomas W; Lindholm D; Maza RM
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1335-1348. PubMed ID: 28414080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas-associated factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1.
    Kinoshita T; Kondoh C; Hasegawa M; Imamura R; Suda T
    Int Immunol; 2006 Dec; 18(12):1701-6. PubMed ID: 17046979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
    Shih HM; Chang CC; Kuo HY; Lin DY
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor.
    Murai-Takeda A; Shibata H; Kurihara I; Kobayashi S; Yokota K; Suda N; Mitsuishi Y; Jo R; Kitagawa H; Kato S; Saruta T; Itoh H
    J Biol Chem; 2010 Mar; 285(11):8084-93. PubMed ID: 20054001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci.
    Sudharsan R; Azuma Y
    J Cell Sci; 2012 Dec; 125(Pt 23):5819-29. PubMed ID: 22976298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
    Chen A; Wang PY; Yang YC; Huang YH; Yeh JJ; Chou YH; Cheng JT; Hong YR; Li SS
    J Cell Biochem; 2006 Jul; 98(4):895-911. PubMed ID: 16475184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor/extracellular signal-regulated kinase pathway enhances mineralocorticoid receptor transcriptional activity through protein stabilization.
    Mitsuishi Y; Shibata H; Kurihara I; Kobayashi S; Yokota K; Murai-Takeda A; Hayashi T; Jo R; Nakamura T; Morisaki M; Itoh H
    Mol Cell Endocrinol; 2018 Sep; 473():89-99. PubMed ID: 29391190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.